Address
9075 South Sandy Parkway
Sandy, UT
84070, United States
Contact
Matthew L Tebeau+13144036936
mtebeau@omnilytics.com
Website
Controlling bacterial disease without antibiotics
We have developed bacteriophages for application in crop science, animal health, food safety as well as human applications.
Reduces the need for antibiotics and chemicals (like copper) that causes disease, create AMR, and reduce productivity.
- Infection prevention
- Antimicrobial stewardship
- Antimicrobial compound/strategy
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Marketed product
- Research
- Development
- Validation
- Market entry
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Outsource
- Joint Venture
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- RTI
- GII
- SSTI
- SSI
- BSI
- CNSI
- IAI
Geographic origin:
- North America
- South America
- Eurasia
- Africa
- Oceania
N.A.
Phagelux Agrihealth, and its subsidiary Omnilytics, are changing the way the world addresses bacterial disease in agriculture reducing the need for the use of antibiotics as well as reducing the reservoirs of anti-microbial resistance.
We have a sister company developing phage applications in wound care as well as in human drug applications.
We are researching additional applications in human health as well as diagnostic tools to enable higher precision use of bacteriophages in the field.
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!